Verastem, Inc.
Public company- Headquarters
- NEEDHAM, Massachusetts
- Ticker
- VSTM
- CIK
- 0001526119
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEODaniel W. Paterson | Oct 14, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive departure
CEO departs: Daniel W. Paterson
Daniel W. Paterson, President and Chief Executive Officer of Verastem, Inc., retires the role, effective January 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 14, 2026Role: President and Chief Executive Officer
- Executive appointment
CEO appointed: Michael Bailey
Michael Bailey was named President and Chief Executive Officer of Verastem, Inc., effective January 1, 2027. Michael Bailey succeeds Daniel W. Paterson. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 14, 2026Role: President and Chief Executive Officer
Last verified Nov 8, 2026